MANAGEMENT OF ANTICOAGULANT THERAPY IN CORONARY SYNDROMES - TALEB BENDIAB, NABILA;Rabah, Marwa;Mokadem, Nour El Houda
26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
13 °P sammeln
  • Broschiertes Buch

Cardiovascular disease is the leading cause of death worldwide. It is also an important cause of morbidity and hospitalization. Acute coronary syndrome is the most severe form of coronary artery disease, resulting in high mortality or recurrent coronary events, especially in developing countries. Anticoagulant therapy is a cornerstone of the management of acute coronary syndrome, especially with the advent of direct oral anticoagulants (DOACs).The choice of the appropriate anticoagulant therapy depends on several intrinsic and extrinsic factors related to each patient. For this reason, the…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Cardiovascular disease is the leading cause of death worldwide. It is also an important cause of morbidity and hospitalization. Acute coronary syndrome is the most severe form of coronary artery disease, resulting in high mortality or recurrent coronary events, especially in developing countries. Anticoagulant therapy is a cornerstone of the management of acute coronary syndrome, especially with the advent of direct oral anticoagulants (DOACs).The choice of the appropriate anticoagulant therapy depends on several intrinsic and extrinsic factors related to each patient. For this reason, the learned societies of cardiology try to update the recommendations for the management of cardiovascular diseases on a daily basis.
Autorenporträt
La profesora Nabila TALEB BENDIAB (esposa SOUFI) es profesora titular de cardiología y directora de la unidad de hospitalización. Su unidad recibe regularmente un número considerable de pacientes que sufren síndromes coronarios agudos, cuyo manejo se basa esencialmente en la gestión adecuada del tratamiento anticoagulante.